UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders
暂无分享,去创建一个
D. Baker | J. Ramos | J. Fernández-Ruiz | S. Ortega‐Gutiérrez | G. Pryce | E. Lago | A. Cabranes | Mariluz López-Rodríguez